Federated Hermes, Inc. Novavax Inc Transaction History

Federated Hermes, Inc.

$43.9 Billion
Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 56,124 shares of NVAX stock, worth $407,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,124

Previous 50,506 11.12%

Holding current value

$407,460

Previous $406,000 11.58%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$6.41 - $10.82 $36,011 - $60,786	5,618 Added 11.12%	56,124 $359,000
Q4 2024 Feb 13, 2025	BUY	$7.22 - $14.68 $15,335 - $31,180	2,124 Added 4.39%	50,506 $406,000
Q3 2024 Nov 13, 2024	SELL	$10.71 - $17.11 $11,202 - $17,897	-1,046 Reduced 2.12%	48,382 $611,000
Q2 2024 Aug 08, 2024	BUY	$3.89 - $20.97 $15,735 - $84,823	4,045 Added 8.91%	49,428 $625,000
Q1 2024 May 14, 2024	SELL	$3.76 - $6.02 $27,560 - $44,126	-7,330 Reduced 13.91%	45,383 $216,000
Q4 2023 Jan 31, 2024	SELL	$4.8 - $7.67 $1.96 Million - $3.14 Million	-409,114 Reduced 88.59%	52,713 $253,000
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $1.64 Million - $2.34 Million	240,514 Added 108.68%	461,827 $3.34 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $944,738 - $1.35 Million	141,640 Added 177.78%	221,313 $1.64 Million
Q1 2023 May 08, 2023	BUY	$5.76 - $12.48 $346,890 - $751,595	60,224 Added 309.65%	79,673 $552,000
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $134,521 - $380,182	15,183 Added 355.91%	19,449 $199,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $26,317 - $110,069	-1,446 Reduced 25.32%	4,266 $78,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $967,841 - $2.01 Million	-26,677 Reduced 82.36%	5,712 $294,000
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $2.26 Million - $4.63 Million	32,389 New	32,389 $2.39 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $418,781 - $891,795	-3,461 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $391,023 - $1.11 Million	3,461 New	3,461 $628,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $1.85 Million - $3.28 Million	-23,519 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $4.2 Million - $9.44 Million	-52,860 Reduced 69.21%	23,519 $2.55 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $663,325 - $4 Million	47,859 Added 167.81%	76,379 $6.37 Million
Q1 2020 May 13, 2020	SELL	$3.93 - $16.0 $107,351 - $437,056	-27,316 Reduced 48.92%	28,520 $387,000
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $147,791 - $209,071	40,052 Added 253.75%	55,836 $222,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $5,041 - $9,831	1,254 Added 8.63%	15,784 $79,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $71,632 - $177,266	14,530 New	14,530 $85,000

Others Institutions Holding NVAX

# of Institutions

299

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $568M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Novavax Inc Transaction History